The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 333:130 July 13, 1995 Number 2
NextNext

Images in Clinical Medicine: Corticosteroid Osteonecrosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Chin, C. T.
-PubMed Citation
To the Editor: Chin and Sarno (Feb. 23 issue)1 state, ``Osteonecrosis can also occur with short-term use of corticosteroids.'' This statement is inexact and incomplete, and it could be used unfairly by lawyers in malpractice suits.

My colleagues and I have reviewed the international literature for any evidence that short-term treatment (less than 2 weeks) with moderate doses of prednisone (starting at 40 mg per day given orally, with the dose reduced over a period ranging from 6 to 14 days) in adults is associated with osteonecrosis. My experience is that this association is not present in a specific subgroup . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.